Indolent Lymphoma
specificA non-Hodgkin lymphoma with an indolent clinical course.
17
Centers
2
Active Trials
—
Cancer Funding
Top Centers for Indolent Lymphoma(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 72.8 |
| 2 | Cleveland Clinic Cancer CenterCleveland, OH High-Volume Research Center | 72.8 |
| 3 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 50.3 |
| 4 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 50.3 |
| 5 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 50.3 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 50.3 |
| 7 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 50.3 |
| 8 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 50.3 |
| 9 | NCI Comprehensive | 50.3 |
| 10 | NCI Clinical | 50.3 |
| 11 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 50.3 |
| 12 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 50.3 |
| 13 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 50.3 |
| 14 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 50.3 |
| 15 | University of Illinois Cancer CenterChicago, IL | 50.3 |
| 16 | Boston University Cancer CenterBoston, MA | 50.3 |
| 17 | BC CancerVancouver, BC | 50.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →